NZ700467A - Treatments suitable for malassezia infections - Google Patents
Treatments suitable for malassezia infectionsInfo
- Publication number
- NZ700467A NZ700467A NZ700467A NZ70046713A NZ700467A NZ 700467 A NZ700467 A NZ 700467A NZ 700467 A NZ700467 A NZ 700467A NZ 70046713 A NZ70046713 A NZ 70046713A NZ 700467 A NZ700467 A NZ 700467A
- Authority
- NZ
- New Zealand
- Prior art keywords
- malassezia
- treatments suitable
- infections
- amino acids
- malassezia infections
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 206010056131 Tinea versicolour Diseases 0.000 title 1
- 241000555676 Malassezia Species 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Polyamides (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1204457.4A GB201204457D0 (en) | 2012-03-14 | 2012-03-14 | Polypeptides and their use |
| US201261620833P | 2012-04-05 | 2012-04-05 | |
| PCT/GB2013/000112 WO2013136040A1 (en) | 2012-03-14 | 2013-03-14 | Polypeptides and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ700467A true NZ700467A (en) | 2016-08-26 |
Family
ID=46026493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ700467A NZ700467A (en) | 2012-03-14 | 2013-03-14 | Treatments suitable for malassezia infections |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20140155321A1 (enExample) |
| EP (1) | EP2825261A1 (enExample) |
| JP (1) | JP2015516943A (enExample) |
| KR (1) | KR20140138940A (enExample) |
| CN (1) | CN104428036A (enExample) |
| AU (1) | AU2013234122A1 (enExample) |
| CA (1) | CA2866837A1 (enExample) |
| CL (1) | CL2014002397A1 (enExample) |
| GB (1) | GB201204457D0 (enExample) |
| HK (1) | HK1201050A1 (enExample) |
| IL (1) | IL234646A0 (enExample) |
| MX (1) | MX2014010996A (enExample) |
| NZ (1) | NZ700467A (enExample) |
| RU (1) | RU2014139857A (enExample) |
| SG (1) | SG11201405539QA (enExample) |
| WO (1) | WO2013136040A1 (enExample) |
| ZA (1) | ZA201407276B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2981037C (en) * | 2015-04-03 | 2019-04-30 | Elc Management Llc | Hair treatment compositions comprising hydrolyzed wheat protein and polyquaternium-6 |
| JP6553961B2 (ja) * | 2015-06-25 | 2019-07-31 | 花王株式会社 | 美白剤 |
| WO2017047299A1 (ja) * | 2015-09-15 | 2017-03-23 | 富士フイルム株式会社 | 注射用液剤組成物 |
| CN109700834A (zh) * | 2019-01-18 | 2019-05-03 | 上海市农业科学院 | 一种蛹虫草固体发酵物及其抗菌用途 |
| AR122485A1 (es) | 2020-06-04 | 2022-09-14 | Syngenta Crop Protection Ag | Composiciones fungicidas |
| CN115381928B (zh) * | 2022-10-27 | 2022-12-27 | 山东中医药大学附属医院 | 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用 |
| JP2024082709A (ja) * | 2022-12-09 | 2024-06-20 | 日本メナード化粧品株式会社 | 抗菌剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1927597T3 (en) * | 2004-08-18 | 2017-02-13 | Novabiotics Ltd | ANTIBACTERIAL PEPTIDES |
| GB0611115D0 (en) * | 2006-06-06 | 2006-07-19 | Novabiotics Ltd | Compounds and their use |
| GB0702020D0 (en) * | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| GB0702022D0 (en) * | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| EP2224901A1 (en) * | 2007-12-21 | 2010-09-08 | Basf Se | Anti-dandruff compositions containing peptides |
-
2012
- 2012-03-14 GB GBGB1204457.4A patent/GB201204457D0/en not_active Ceased
-
2013
- 2013-03-14 NZ NZ700467A patent/NZ700467A/en not_active IP Right Cessation
- 2013-03-14 JP JP2014561504A patent/JP2015516943A/ja active Pending
- 2013-03-14 MX MX2014010996A patent/MX2014010996A/es unknown
- 2013-03-14 SG SG11201405539QA patent/SG11201405539QA/en unknown
- 2013-03-14 HK HK15101528.2A patent/HK1201050A1/xx unknown
- 2013-03-14 KR KR1020147028818A patent/KR20140138940A/ko not_active Withdrawn
- 2013-03-14 US US14/004,344 patent/US20140155321A1/en not_active Abandoned
- 2013-03-14 AU AU2013234122A patent/AU2013234122A1/en not_active Abandoned
- 2013-03-14 WO PCT/GB2013/000112 patent/WO2013136040A1/en not_active Ceased
- 2013-03-14 EP EP13718609.4A patent/EP2825261A1/en not_active Ceased
- 2013-03-14 CN CN201380014410.5A patent/CN104428036A/zh active Pending
- 2013-03-14 RU RU2014139857A patent/RU2014139857A/ru not_active Application Discontinuation
- 2013-03-14 CA CA2866837A patent/CA2866837A1/en not_active Abandoned
-
2014
- 2014-09-10 CL CL2014002397A patent/CL2014002397A1/es unknown
- 2014-09-14 IL IL234646A patent/IL234646A0/en unknown
- 2014-10-07 ZA ZA2014/07276A patent/ZA201407276B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2014139857A (ru) | 2016-05-10 |
| CA2866837A1 (en) | 2013-09-19 |
| HK1201050A1 (en) | 2015-08-21 |
| EP2825261A1 (en) | 2015-01-21 |
| CL2014002397A1 (es) | 2015-02-27 |
| IL234646A0 (en) | 2014-11-30 |
| US20140155321A1 (en) | 2014-06-05 |
| WO2013136040A1 (en) | 2013-09-19 |
| CN104428036A (zh) | 2015-03-18 |
| KR20140138940A (ko) | 2014-12-04 |
| AU2013234122A1 (en) | 2014-10-16 |
| SG11201405539QA (en) | 2014-10-30 |
| GB201204457D0 (en) | 2012-04-25 |
| JP2015516943A (ja) | 2015-06-18 |
| ZA201407276B (en) | 2015-06-24 |
| MX2014010996A (es) | 2014-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201491773A1 (ru) | Лечение рассеянного склероза комбинацией лаквинимода и диметилфумарата | |
| PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| WO2017009843A3 (en) | Compositions, articles of manufacture and methods for treating cancer | |
| PH12014501738A1 (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| MX341324B (es) | Polipeptidos. | |
| PH12015500724A1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
| IN2014MN02089A (enExample) | ||
| IN2014MN02236A (enExample) | ||
| GB201118201D0 (en) | Novel peptides | |
| MX2016007626A (es) | Peptido antimicrobiano y usos del mismo. | |
| HK1201050A1 (en) | Polypeptides and their use | |
| MX2019011908A (es) | Macrociclos de peptidos anti-bacterianos y uso de los mismos. | |
| MY168778A (en) | Oligonucleotide chelate complex-polypeptide compositions and methods | |
| EA201491532A1 (ru) | Фармацевтические композиции для использования в комплексной терапии | |
| AU2012280776B2 (en) | Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases | |
| HK1199201A1 (en) | Antimicrobial peptides for treatment of infectious diseases | |
| JP2017517561A5 (enExample) | ||
| PH12014502065A1 (en) | Vesicular formulations | |
| EP4219534A3 (en) | Methods for treatment of and prophylaxis against inflammatory disorders | |
| IN2014DN08610A (enExample) | ||
| WO2013084070A3 (en) | Salmonella vaccine proteins | |
| SG10201809673RA (en) | Treatment of androgen deprivation therapy associated symptoms | |
| MX2015006779A (es) | Proteina slurp-1 para usarse en el tratamiento de enfermedades oculares. | |
| EP4566668A3 (en) | Neurotoxins for use in minimizing scarring | |
| WO2015200768A3 (en) | Pharmacologic treatments of menière's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |